跳至主要内容
临床试验/RBR-8vsb7k2
RBR-8vsb7k2进行中(未招募)4 期

Evaluation of Intra-Erythrocyte, Serum and Total Magnesium concentrations in patients undergoing Chemotherapy with Platinum derivatives in association with Proton Pump Inhibitors and their correlation with Neuropathies

IVERSIDADE FEDERAL DO RIO GRANDE DO NORTE0 个研究点开始时间: 2021年1月19日最近更新:
适应症

试验速览

阶段
4 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
18 至 0(—)

入选标准

  • Age over 18 years; Starting chemotherapy with a regime containing cisplatin, carboplatin or oxaliplatin; Chemotherapy regimen of 1 day or 5 consecutive days; Agree to participate by signing the Free and Informed Consent Form

排除标准

  • Not having moderate to severe kidney disease or advanced disease with a life expectancy of less than 6 months; Having no history of hypersensitivity to any of the components of the omeprazole or placebo formulation; You must not have concomitant therapy with warfarin, atazanavir, tacrolimus or voriconazole; Patients taking diazepam, phenytoin or ampicillin may be included but the doses of these drugs should be adjusted.

研究者

发起方
IVERSIDADE FEDERAL DO RIO GRANDE DO NORTE

相似试验